-

Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that its Advanced Technologies & Life Sciences business was selected by Agilent Technologies, Inc., to expand its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado, just north of Denver. Fluor is supporting engineering and procurement as part of the project. The total project value is $725 million.

“Speed to market is essential in the pharmaceutical industry,” said Juan Hernández, president of Fluor’s Advanced Technologies & Life Sciences business. “We will incorporate state-of-the-art engineering enhancements such as advanced automation, water reduction strategies and solvent capturing to optimize cost and construction. This enables us to fast-track the project so that Agilent can meet its global customers’ needs by getting products to market faster.”

Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability. The completed facility will provide for the synthesis, purification and lyophilization of Agilent’s custom nucleic acids therapeutics, also known as oligonucleotides or oligos.

Oligos are short deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules that serve as the active pharmaceutical ingredients for drugs targeting a growing number of diseases, including cancer, cardiovascular disease, and rare and infectious diseases.

Construction is underway with completion expected by 2026.

About Fluor Corporation

Fluor Corporation (NYSE: FLR) is building a better world by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 41,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. Fluor had revenue of $12.4 billion in 2021 and is ranked 259 among the Fortune 500 companies. With headquarters in Irving, Texas, Fluor has provided engineering, procurement and construction services for more than 110 years. For more information, please visit www.fluor.com or follow Fluor on Twitter, LinkedIn, Facebook and YouTube.

#atls

Contacts

Brian Mershon
Media Relations
469.398.7621

Jason Landkamer
Investor Relations
469.398.7222

Fluor Corporation

NYSE:FLR

Release Versions

Contacts

Brian Mershon
Media Relations
469.398.7621

Jason Landkamer
Investor Relations
469.398.7222

More News From Fluor Corporation

Fluor Receives $1.35 Billion for 71 Million NuScale Shares; Launches Trading Program for Remaining 40 Million Shares

IRVING, Texas--(BUSINESS WIRE)--FLUOR RECEIVES $1.35 BILLION FOR 71 MILLION NUSCALE SHARES; LAUNCHES TRADING PROGRAM FOR REMAINING 40 MILLION SHARES...

Fluor Reports Fourth Quarter and Full Year 2025 Results

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced financial results for its year ended December 31, 2025. “Our growing confidence in capturing significant EPC awards in 2026 and into 2027 is supported by an improving capital spending environment and increasing client commitments,” said Jim Breuer, chief executive officer of Fluor. “Furthermore, I am pleased that the monetization of our NuScale investment is progressing well and that we are returning significant value to ou...

Fluor Selected as Engineering, Procurement and Construction Partner for Expansion of Centrus’ Uranium Enrichment Plant in Ohio

IRVING, Texas--(BUSINESS WIRE)--Fluor Selected as Engineering, Procurement and Construction Partner for Expansion of Centrus’ Uranium Enrichment Plant in Ohio...
Back to Newsroom